Rebuilding AI and pharma supply chains

U.S. experts highlight the need to rebuild pharmaceutical and AI supply chains to strengthen resilience, noting that reshoring alone is insufficient due to complex dependencies and skill shortages. Efforts include stockpiling active pharmaceutical ingredients and recognising the slow build of critical infrastructure versus fast-evolving AI demands.

This Wire brief sits within Fusion42's coverage of Biotech.